Novel diamidines with activity against Babesia divergens in vitro and Babesia microti in vivo

Antimicrobial Agents and Chemotherapy

Volumn 55, Issue 7, 2011, Pages 3439-3445

  Nehrbass Stuedli, Angela ^a   Boykin, David ^c   Tidwell, Richard R ^d   Brun, Reto ^a,b  

^a SWISS TROPICAL AND PUBLIC HEALTH INSTITUTE   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

^c GEORGIA STATE UNIVERSITY   (United States)

^d UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIPROTOZOAL AGENT; ATOVAQUONE; AZA FURAN; BENZIMIDAZOLE DERIVATIVE; BIPHENYL DERIVATIVE; CARBESIA; DB 0103; DB 0921; DB 0922; DB 0940; DB 0942; DB 1172; DB 1190; DB 1191; DB 1193; DB 1236; DB 1250; DIAMIDINE DERIVATIVE; DIMINAZENE ACETURATE; DIPHENYL FURAN; FURAN DERIVATIVE; GUANIDINO INDENE; IMIDOCARB DIPROPIONATE; INDENE DERIVATIVE; INDOLE DERIVATIVE; ISOXAZOLE DERIVATIVE; PENTAMIDINE; PENTAMIDINE DERIVATIVE; TERPHENYL DERIVATIVE; THIOPHENE DERIVATIVE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPROTOZOAL ACTIVITY; ARTICLE; BABESIA DIVERGENS; BABESIA MICROTI; BABESIOSIS; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTIPROTOZOAL AGENTS; BABESIA; BABESIA MICROTI; BABESIOSIS; BENZIMIDAZOLES; FEMALE; FURANS; MICE; PARASITEMIA; PENTAMIDINE; TERPHENYL COMPOUNDS;

EID: 79959247148     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.01482-10     Document Type: Article

References (31)

1. Batista-Parra, A. 2003. Synthesis of 5-[2-(5-amidinobenzimidazoyl)-2-(4- amidinophenyl)furan hydrochloride to test a DNA minor groove dimer binding model. Diss. Abstr. Int. B 63:5843.
2. Bell, C. A., et al. 1990. Structure-activity relationship of analogs of pentamidine against Plasmodium falciparum and Leishmania mexicana amazonensis. Antimicrob. Agents Chemother. 34:1381-1386.
3. Boykin, D. W., et al. 1995. Dicationic diarylfurans as anti-Pneumocystis carinii agents. J. Med. Chem. 38:912.
4. Brasseur, P., S. Lecoublet, N. Kapel, L. Favennec, and J. J. Ballet. 1998. In vitro evaluation of drug susceptibilities of Babesia divergens isolates. Antimicrob. Agents Chemother. 42:818-820.
5. Das, B. P., and D. W. Boykin. 1977. Synthesis and antiprotozoal activity of 2,5-bis-(4 guanylphenyl)furans. J. Med. Chem. 20:531.
6. Del Poeta, M., et al. 1998. Structure-in vitro activity relationships of pentamidine analogues and dicationic substituted bis-benzamidazoles as new antifungal agents. Antimicrob. Agents Chemother. 42:2495-2510.
7. Ganapaty, S., P. Steve Thomas, G. Karagianis, P. G. Waterman, and R. Brun. 2006. Antiprotozoal and cytotoxic naphthalene derivatives from Diospyros assimilis. Phytochemistry 67(17):1950-1956. (Pubitemid 44382675)
8. Granström, M. 1997. Tick-borne zoonoses in Europe. Clin. Microbiol. Infect. 3:156-169.
9. Gray, J. S., and M. Pudney. 1999. Activity of atovaquone against Babesia microti in the Mongolian gerbil, Meriones unguiculatus. J. Parasitol. 85(4): 723-728. (Pubitemid 29383141)
10. Hughes, W. T., and H. S. Oz. 1995. Successful prevention and treatment of babesiosis with atovaquone. J. Infect. Dis. 172(4):1042-1046.
11. Ismail, M. A., et al. 2005. Dicationic near-linear biphenyl benzimidazole derivatives as DNA-targeted antiprotozoal agents. Bioorg. Med. Chem. 13: 6718-6726.
12. Ismail, M. A., et al. 2004. Novel dicationic imidazo[1,2-a]pyridines and 5,6,7,8-tetrahydro-imidazo[1,2-a]pyridines as antiprotozoal agents. J. Med. Chem. 47:3658-3664.
13. Ismail, M. A., R. Brun, F. Tanious, W. D. Wilson, and D. W. Boykin. 2003. Synthesis and anti-protozoal activity of aza-analogs of furamidine. J. Med. Chem. 46:4761-4769.
14. Kjemtrup, A. M., and P. A. Conrad. 2000. Human babesiosis: an emerging tick-borne disease. Int. J. Parasitol. 30:1323-1337.
15. Kocken, C. H., et al. 2006. Plasmodium vivax: in vitro susceptibility of blood stages to synthetic trioxolane compounds and the diamidine DB75. Exp. Parasitol. 113:197-200.
16. Korsinczky, M., et al. 2000. Mutations in Plasmodium falciparum cytochrome b that are associated with atovaquone resistance are located at a putative drug-binding site. Antimicrob. Agents Chemother. 44:2100-2108.
17. Krause, P. J., T. Lepore, V. K. Sikand, J. Gadbaw, Jr., et al. 2000. Atovaquone and azithromycin for the treatment of babesiosis. N. Engl. J. Med. 343(20):1454-1458.
18. Krause, P. J., et al. 2008. Persistent and relapsing babesiosis in immunocompromised patients. Clin. Infect. Dis. 46(3):370-376.
19. Mallena, S., et al. 2004. A thiophene based diamidine forms a "super" AT binding minor groove agent. J. Am. Chem. Soc. 126:13659-13669.
20. Miller, L. H., F. A. Neva, and F. Gill. 1978. Failure of chloroquine in human babesiosis (Babesia microti): case report and chemotherapeutic trials in hamsters. Ann. Intern. Med. 88:200-202.
21. Page, C., M. Page, and C. Noel. 1993. Fluorometric assay for cytotoxicity measurements in vitro. Int. J. Oncol. 3:473-476.
22. Pudney, M., and J. S. Gray. 1997. Therapeutic efficacy of atovaquone against the bovine intraerythrocytic parasite, Babesia divergens. J. Parasitol. 83(2): 307-310. (Pubitemid 27167225)
23. Räz, B., M. Iten, Y. Grether-Buhler, R. Kaminsky, and R. Brun. 1997. The Alamar Blue assay to determine drug sensitivity of African trpyanosomes (T.b. rhodesiense and T.b. gambiense) in vitro. Acta Trop. 68(2):139-147. (Pubitemid 27438330)
24. Ruebush, T. K., P. G. Contacos, and E. A. Steck. 1980. Chemotherapy of Babesia microti infections in Mongolian jirds. Antimicrob. Agents Chemother. 18:289-291.
25. Stead, A. M., et al. 2001. Diamidine compounds: selective uptake and targeting in Plasmodium falciparum. Mol. Pharmacol. 59:1298-1306.
26. Tidwell, R. R., and D. W. Boykin. 2003. Dicationic DNA minor groove binders as antimicrobial agents, p. 414-460. In M. Demeunynck, C. Bailly, and W. D. Wilson (ed.), DNA and RNA binders: from small molecules to drugs, vol. 2. Wiley-VHC Verlag GmbH, Weinheim, Germany.
27. Tidwell, R. R., et al. 1978. Diarylamidine derivatives with one or both of the aryl moieties consisting of an indole or indole-like ring. Inhibitors of arginine- specific esteroproteases. J. Med. Chem. 21:613.
28. Vannier, E., B. E. Gewurz, and P. J. Krause. 2008. Human babesiosis. Infect. Dis. Clin. North Am. 22:469-488.
29. Vial, H. J., and A. Gorenflot. 2006. Chemotherapy against babesiosis. Vet. Parasitol. 138:147-160.
30. Weiss, L. M. 2002. Babesiosis in humans: a treatment review. Expert Opin. Pharmacother. 3:1109-1115.
31. Wittner, M., J. Ledermann, H. B. Tanowitz, G. S. Rosenbaum, and L. M. Weiss. 1996. Atovaquone in the treatment of Babesia microti infections in hamsters. Am. J. Trop. Med. Hyg. 55(2):219-222.